EP3250600
Meðhöndlun sjálfsónæmiskvilla með CD154 mótefnum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.4.2015EP published:
6.5.2020EP application number:
15719675.9
EP translation filed:
26.5.2020Grant published:
15.6.2020EPO information:
European Patent Register
Max expiry date:
26.4.2035Expiry date:
26.4.2026Next due date:
30.4.2026
Title:
TREATMENT OF AUTOIMMUNE DISORDERS WITH CD154 ANTIBODIES
Timeline
Today
27.4.2015EP application
6.5.2020EP Publication
26.5.2020Translation submitted
15.6.2020Registration published
26.4.2026Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allée de la Recherche 60, 1070 Brussels, BE
Name:
Biogen MA Inc.Address:
225 Binney Street, Cambridge, MA 02142, US
Inventor
Name:
OLIVER, RuthAddress:
Slough Berkshire SL1 3WE, GB
Name:
ZAMACONA, MirenAddress:
Slough Berkshire SL1 3WE, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201501613Date:
30.1.2015Country:
GB
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.3.2021
Expires: 26.4.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.3.2022
Expires: 26.4.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.3.2023
Expires: 26.4.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.3.2024
Expires: 26.4.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 18.3.2025
Expires: 26.4.2026
Payer: Árnason Faktor ehf.